Treatments That Hold Promise for Dermatomyositis
Julie Paik, MD, MHS, discusses JAK inhibitors in dermatomyositis (DM).
00:16 Background
01:01 Remission of Form of DM Treated with Ruxolitinib - Case Study
02:22 Tofacitinib in DM - Case Study
03:46 Tofacitinib in DM - Case Study - Hypothesis
04:25 Tofacitinib in DM - Case Study - Criteria for Study
05:53 Tofacitinib in DM - Case Study - Study Design
06:44 Tofacitinib in DM - Case Study - Results
10:53 Tofacitinib in DM - Case Study - Conclusions
Видео Treatments That Hold Promise for Dermatomyositis канала Cure JM Foundation
00:16 Background
01:01 Remission of Form of DM Treated with Ruxolitinib - Case Study
02:22 Tofacitinib in DM - Case Study
03:46 Tofacitinib in DM - Case Study - Hypothesis
04:25 Tofacitinib in DM - Case Study - Criteria for Study
05:53 Tofacitinib in DM - Case Study - Study Design
06:44 Tofacitinib in DM - Case Study - Results
10:53 Tofacitinib in DM - Case Study - Conclusions
Видео Treatments That Hold Promise for Dermatomyositis канала Cure JM Foundation
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Overview and new developments in Dermatomyositis with Dr. Victoria Werth, MDMyositis and lung diseases, Dr Sonye DanoffLife with Dermatomyositis: Mike's StoryNutrition and inflammatory diseaseDermatomyositis - Treatment | Johns HopkinsDermatomyositisMyositis Specific AntibodiesComplications of Myositis, Dr Andrew MammenCOVID-19 Vaccination and MyositisComplications From Myositis, Dr Rossitza ChichkovaNew Developments on the Role of Itch in Dermatomyositis by Dr. Victoria WerthIdiopathic Inflammatory Myopathies | Polymyositis vs DermatomyositisJulie's Dermatomyositis Symptoms & Life with the DiseaseExercise for Every LevelLiving with Dermatomyositis: Marilyn's StoryHow to treat Perioral Dermatitis- Dermatologist ExplainsResults of the Phase 3 Clinical Trial on IVIG in DermatomyositisPolymyositis Treatment : Johns Hopkins Myositis CenterPolymyositis Overview : Johns Hopkins Myositis CenterLaura's Life with Dermatomyositis